Researchers at Columbia University are acting on a hypothesis that a high-CBD, low-THC strain of cannabis will be well tolerated in patients with an aggressive form of brain cancer and may decrease radiation-induced toxicities and nausea while improving mood and quality of life.
Approximately 15 patients suffering glioblastoma will smoke between one-half to two cannabis cigarettes over a two- hour session before receiving chemo-radiation.
The phase one clinical trial will assess food intake, opioid use and compliance to cannabis treatment.
Sponsored by New York State Psychiatric Institute, the study is estimated to be completed by the end of next year.
Cannabis Findings 